Barns, P, Bloom, B & Nahin, R (2008) Complementary and alternative medicine use among adults and children. CDC National Health Statistics Report no. 12. http://www.cdc.gov/nchs/data/nhsr/nhsr012.pdf (accessed August 2015).
Millen, AE, Dodd, KW & Subar, AF (2004) Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc
Guo, X, Willows, N, Kuhle, S, et al. (2009) Use of vitamin and mineral supplements among Canadian adults. Can J Public Health Rev Can Santé Publique
Albert, CM, Campos, H, Stampfer, MJ, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med
Calder, PC (2015) Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim Biophys Acta
Daiello, LA, Gongvatana, A, Dunsiger, S, et al. (2015) Association of fish oil supplement use with preservation of brain volume and cognitive function. Alzheimers Dement
Harris, WS (2010) The omega-3 index: clinical utility for therapeutic intervention. Curr Cardiol Rep
Khorsan, R, Crawford, C, Ives, JA, et al. (2014) The effect of omega-3 fatty acids on biomarkers of inflammation: a rapid evidence assessment of the literature. Mil Med
11 Suppl., 2–60.
Janssen, CI & Kiliaan, AJ (2014) Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: the influence of LCPUFA on neural development, aging, and neurodegeneration. Prog Lipid Res
Shaikh, NA, Yantha, J, Shaikh, S, et al. (2014) Efficacy of a unique omega-3 formulation on the correction of nutritional deficiency and its effects on cardiovascular disease risk factors in a randomized controlled VASCAZEN((R)) REVEAL trial. Mol Cell Biochem
Shaikh, U, Byrd, RS & Auinger, P (2009) Vitamin and mineral supplement use by children and adolescents in the 1999–2004 National Health and Nutrition Examination Survey: relationship with nutrition, food security, physical activity, and health care access. Arch Pediatr Adolesc Med
Albert, BB, Cameron-Smith, D, Hofman, PL, et al. (2013) Oxidation of marine omega-3 supplements and human health. Biomed Res Int
2013, article ID 464921.
Shahidi, F & Zhong, Y (2010) Lipid oxidation and improving the oxidative stability. Chem Soc Rev
Garcia-Hernandez, VM, Gallar, M, Sanchez-Soriano, J, et al. (2013) Effect of omega-3 dietary supplements with different oxidation levels in the lipidic profile of women: a randomized controlled trial. Int J Food Sci Nutr
Esterbauer, H (1993) Cytotoxicity and genotoxicity of lipid-oxidation products. Am J Clin Nutr
57, 5 Suppl., 779S–785S.
Bartsch, H & Nair, J (2006) Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbecks Arch Surg
Ritter, JC & Budge, SM (2012) Key lipid oxidation products can be used to predict sensory quality of fish oils with different levels of EPA and DHA. Lipids
Fierens, C, Corthout, J (2007) Omega-3 fatty acid preparations – a comparative study. J Pharm Belg
Kolanowski, W (2010) Omega-3 LC PUFA contents and oxidative stability of encapsulated fish oil dietary supplements. Int J Food Prop
Opperman, M, Marais de, W & Spinnler Benade, AJ (2011) Analysis of omega-3 fatty acid content of South African fish oil supplements. Cardiovasc J Afr
Opperman, M & Benade, S (2013) Analysis of the omega-3 fatty acid content of South African fish oil supplements: a follow-up study. Cardiovasc J Afr
Albert, BB, Derraik, JG, Cameron-Smith, D, et al. (2015) Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA. Sci Rep
Fantoni, C, Cuccio, A & Barrera-Arellano, D (1996) Brazilian encapsulated fish oils: oxidative stability and fatty acid composition. J Am Oil Chem Soc
American Oil Chemists’ Society (2003) AOCS Official Method CD 8–53. Official Methods and Recommended Practises of the American Oil Chemists’ Society. Champaign, IL: AOCS.
American Oil Chemists’ Society (2003) AOCS Official Method CD 18–90. Official Methods and Recommended Practises of the American Oil Chemists’ Society. Champaign, IL: AOCS.
Ballantyne, CM, Bays, HE, Kastelein, JJ, et al. (2012) Efficacy and safety of eicosapentaenoic acid ethyl ester (AMR101) therapy in statin-treated patients with persistent high triglycerides (from the ANCHOR study). Am J Cardiol
Braeckman, RA, Manku, MS, Bays, HE, et al. (2013) Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study). Prostaglandins Leukot Essent Fatty Acids
Nelson, SD & Munger, MA (2013) Icosapent ethyl for treatment of elevated triglyceride levels. Ann Pharmacother